rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2007-2-19
|
pubmed:databankReference |
|
pubmed:abstractText |
To compare the efficacy of etoricoxib 30 mg with the generally maximum recommended dose of celecoxib, 200 mg, in the treatment of osteoarthritis (OA) in two identically designed studies.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1462-0324
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
496-507
|
pubmed:dateRevised |
2008-12-4
|
pubmed:meshHeading |
pubmed-meshheading:16936327-Adult,
pubmed-meshheading:16936327-Aged,
pubmed-meshheading:16936327-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:16936327-Blood Pressure,
pubmed-meshheading:16936327-Cyclooxygenase 2 Inhibitors,
pubmed-meshheading:16936327-Double-Blind Method,
pubmed-meshheading:16936327-Female,
pubmed-meshheading:16936327-Follow-Up Studies,
pubmed-meshheading:16936327-Gastrointestinal Diseases,
pubmed-meshheading:16936327-Humans,
pubmed-meshheading:16936327-Male,
pubmed-meshheading:16936327-Middle Aged,
pubmed-meshheading:16936327-Osteoarthritis,
pubmed-meshheading:16936327-Osteoarthritis, Hip,
pubmed-meshheading:16936327-Osteoarthritis, Knee,
pubmed-meshheading:16936327-Pyrazoles,
pubmed-meshheading:16936327-Pyridines,
pubmed-meshheading:16936327-Severity of Illness Index,
pubmed-meshheading:16936327-Sulfonamides,
pubmed-meshheading:16936327-Sulfones,
pubmed-meshheading:16936327-Thrombosis,
pubmed-meshheading:16936327-Treatment Outcome
|
pubmed:year |
2007
|
pubmed:articleTitle |
Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.
|
pubmed:affiliation |
Johns Hopkins University Baltimore, MD, USA. Clifton.bingham@jhmi.edu
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|